Options
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial
Journal
The Lancet Gastroenterology & Hepatology
ISSN
2468-1253
Date Issued
2024-07
Author(s)
Nadia Ovchinsky
Madeleine Aumar
Alastair Baker
Ulrich Baumann
Philip Bufler
Mara Cananzi
Piotr Czubkowski
Özlem Durmaz
Ryan Fischer
Giuseppe Indolfi
Wikrom W Karnsakul
Florence Lacaille
Way S Lee
Giuseppe Maggiore
Philip Rosenthal
Mathias Ruiz
Etienne Sokal
Ekkehard Sturm
Wendy van der Woerd
Henkjan J Verkade
Andrew Wehrman
Christine Clemson
Qifeng Yu
Quanhong Ni
Jessica Ruvido
Susan Manganaro
Jan P Mattsson
DOI
10.1016/S2468-1253(24)00074-8
File(s)
Loading...
Name
Picture1.png
Size
3.11 KB
Format
PNG
Checksum
(MD5):21881560e0c3c9c06b18c6e8fdc11acf